Globe Life Inc. Common Stock (NYSE: GL)
The Complaint alleges that, throughout the Class Period, Defendants made numerous materially false and misleading statements and omissions concerning: (i) Globe Life's consistent premium revenue growth, particularly from AIL; and (ii) Globe Life's Code of Business Conduct and Ethics (the "Code of Conduct"). Specifically, the Complaint alleges Defendants repeatedly attributed the Company's consistent premium revenue growth "to increased agent count and productivity." The Complaint alleges that as a result of these misrepresentations, Globe Life common stock traded at artificially inflated prices during the Class Period.